ECEwerton Cousin

Ewerton Cousin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ewerton Cousin has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exposure to and Burden of Major Non-Communicable Disease Risk Factors in Brazil and its States, 1990-2019: The Global Burden of Disease Study

    by Caroline Stein, Maria Inês Schmidt, Ewerton Cousin, Deborah Carvalho Malta, Mohsen Naghavi, Patrícia Pereira Vasconcelos de Oliveira, Antonio Luiz Pinho Ribeiro, Bruce B. Duncan

    Non-Communicable Diseases (NCDs) have become the main cause of disease burden in Brazil. Our objective was to describe trends (1990 to 2019) in prevalence and attributable burden of five modifiable risk factors and related metabolic risk factors in Brazil and its states. In Global Burden of Disease 2019 analyses, we described trends in prevalence of modifiable risk factors and their metabolic mediators as percentage change in Summary Exposure Value (SEV). We estimated deaths and disability-adjusted life years (DALYs) attributable to the risk factors. Age-adjusted exposures to alcohol [41.0%, Uncertainty Interval (UI): 24.2 - 63.4], red meat (61.2%, UI: 42.4-92.3), low physical activity (3.9%, UI: -5-17.5) and ambient particulate matter pollution (3.3%, UI: -48.9-128.0) have worsened. Those for smoking (-51.4%, UI: -54.7- - 47.8), diet low in fruits (-28.1%, UI: -39.1- -18.7) and vegetables (-19.6%, UI: -32.7 - -8.7), and household air pollution (-85.3%, UI: -92.9- -74.3) have improved. All mediating metabolic risk factors, except high blood pressure (0.7%, UI: -6.9-8.3), have worsened: BMI (110.2%, UI: 78.6-161.7), hyperglycemia (15.1%, UI: 9.3-21.2), kidney dysfunction (12.0%, UI: 8.4-17.2), and high LDL-c (11.8%, UI: 6.9-17.2). A variable pattern of progress and failure in controlling modifiable risk factors has been accompanied by major worsening in most metabolic risk factors. The mixed success in public health measures to control modifiable risk factors for NCDs, when gauged by the related trends in metabolic risk factors, alert to the need for stronger actions to control NCDs in the future.


  • Open Access

    Premature mortality due to four main non-communicable diseases and suicide in Brazil and its states from 1990 to 2019: A Global Burden of Disease Study

    by Ewerton Cousin, Maria Inês Schmidt, Caroline Stein, Érika Carvalho de Aquino, Ellen de Cassia Dutra Pozzetti Gouvea, Deborah Carvalho Malta, Mohsen Naghavi, Bruce B. Duncan

    The goal of reducing the burden of non-communicable diseases (NCDs) requires close monitoring. Our objective is to characterize the decline of premature NCD mortality in Brazil based on Global Burden of Diseases (GBD) Study 2019 estimates. We used GBD 2019 data to estimate death rates of the four main NCDs - cardiovascular diseases, neoplasms, diabetes, and chronic respiratory diseases. We estimated the unconditional probability of death between ages 30 to 69, as recommended by the World Health Organization, as well as premature crude- and age-standardized death rates and disability-adjusted life years (DALYs) lost for these conditions. We also estimated trends in suicide (self-harm) death rates. From 2010 to 2019, the age-standardized unconditional probability of premature death declined -1.4%/year (UI: -1.7%;-1.0%) . Age-standardized death rates declined -1.5%/year (UI: -1.9%; -1.2%), and crude death rates -0.6%/year (UI: (-1.0%; -0.2%). Level of development correlated strongly with the rate of decline, with greatest declines occurring in the Southeast, Center West and South regions. Age-standardized mortality from self-harm declined, most notably in the elderly. Premature mortality due to the main NCDs has declined from 1990 in Brazil, although at a diminishing rate over time. The unconditional probability of death and the age-standardized mortality rate produced similar estimates of decline for the four main NCDs, and mirror well decline in mortality from all NCDs. Declines, especially more recent ones, fall short of the international goals. Strategic public health actions are needed. The challenge to implement them will be great, considering the political and economic instability currently faced by Brazil.


  • Open Access

    A pandemia da COVID-19 no Brasil: a série de projeções do Institute for Health Metrics and Evaluation e a evolução observada, maio a agosto de 2020

    by Caroline Stein, Ewerton Cousin, Ísis Eloah Machado, Mariana Santos Felisbino-Mendes, Valéria Maria de Azeredo Passos, Tatiane Moraes de Sousa, Maria Inês Schmidt, John Gallagher, Mohsen Naghavi, Bruce B. Duncan

    Resumo Objetivo Descrever as projeções do Institute for Health Metrics and Evaluation (IHME) para a COVID-19 no Brasil e seus estados, apresentar sua acurácia e discutir suas implicações. Métodos As previsões do IHME de maio a agosto de 2020, para o Brasil e alguns estados, foram comparadas ao número de mortes cumulativas observadas. Resultados A projeção prevê 182.809 mortes causadas pela pandemia até 1º de dezembro de 2020 no Brasil. O aumento no uso de máscara poderia poupar ~17 mil óbitos. O erro médio no número acumulado de óbitos em duas, quatro e seis semanas das projeções foi de 13%, 18% e 22% respectivamente. Conclusão Projeções de curto e médio prazo dispõem dados importantes e acurácia suficiente para informar os gestores de saúde, autoridades eleitas e sociedade geral. Após trajeto difícil até agosto, a pandemia, conforme as projeções, terá declínio sustentado, embora demorado, causando em média 400 óbitos/dia no início de dezembro.


  • Open Access

    The burden of non-communicable diseases attributable to high BMI in Brazil, 1990–2017: findings from the Global Burden of Disease Study

    by Mariana Santos Felisbino-Mendes, Ewerton Cousin, Deborah Carvalho Malta, Ísis Eloah Machado, Antonio Luiz Pinho Ribeiro, Bruce Bartholow Duncan, Maria Inês Schmidt, Diego Augusto Santos Silva, Scott Glenn, Ashkan Afshin, et al.

    Background: The prevalence and burden of disease resulting from obesity have increased worldwide. In Brazil, more than half of the population is now overweight. However, the impact of this growing risk factor on disease burden remains inexact. Using the 2017 Global Burden of Disease (GBD) results, this study sought to estimate mortality and disability-adjusted life years (DALYs) lost to non-communicable diseases caused by high body mass index (BMI) in both sexes and across age categories. This study also aimed to describe the prevalence of overweight and obesity throughout the states of Brazil. Methods: Age-standardized prevalence of overweight and obesity were estimated between 1990 and 2017. A comparative risk assessment was applied to estimate DALYs and deaths for non-communicable diseases and for all causes linked to high BMI. Results: The prevalence of overweight and obesity increased during the period of analysis. Overall, age-standardized prevalence of obesity in Brazil was higher in females (29.8%) than in males (24.6%) in 2017; however, since 1990, males have presented greater rise in obesity (244.1%) than females (165.7%). Increases in prevalence burden were greatest in states from the North and Northeast regions of Brazil. Overall, burden due to high BMI also increased from 1990 to 2017. In 2017, high BMI was responsible for 12.3% (8.8–16.1%) of all deaths and 8.4% (6.3–10.7%) of total DALYs lost to non-communicable diseases, up from 7.2% (4.1–10.8%), and 4.6% (2.4-6.0%) in 1990, respectively. Change due to risk exposure is the leading contributor to the growth of BMI burden in Brazil. In 2017, high BMI was responsible for 165,954 deaths and 5,095,125 DALYs. Cardiovascular disease and diabetes have proven to be the most prevalent causes of deaths, along with DALYs caused by high BMI, regardless of sex or state. Conclusions: This study demonstrates increasing age-standardized prevalence of obesity in all Brazilian states. High BMI plays an important role in disease burdens in terms of cardiovascular diseases, diabetes, and all causes of mortality. Assessing levels and trends in exposures to high BMI and the resulting disease burden highlights the current priority for primary prevention and public health action initiatives focused on obesity.


  • Open Access

    The burden of low back pain in Brazil: estimates from the Global Burden of Disease 2017 Study

    by Caroline Nespolo de David, Lucas de Melo Castro Deligne, Rodolfo Souza da Silva, Deborah Carvalho Malta, Bruce B. Duncan, Valéria Maria de Azeredo Passos, Ewerton Cousin

    Background: The prevalence and burden of musculoskeletal (MSK) conditions are growing around the world, and low back pain (LBP) is the most significant of the five defined MSK disorders in the Global Burden of Disease (GBD) study. LBP has been the leading cause of non-fatal health loss for the last three decades. The objective of this study is to describe the current status and trends of the burden due to LBP in Brazil based on information drawn from the GBD 2017 study. Methods: We estimated prevalence and years lived with disability (YLDs) for LBP by Brazilian federative units, sex, age group, and age-standardized between 1990 and 2017 and conducted a decomposition analysis of changes in age- and sex-specific YLD rates attributable to total population growth and population ageing for the purpose of understanding the drivers of changes in LBP YLDs rates in Brazil. Furthermore, we analyzed the changes in disability-adjusted life years (DALYs) rankings for this disease over the period. Results: The results show high prevalence and burden of LBP in Brazil. LBP prevalence increased 26.83% (95% UI 23.08 to 30.41) from 1990 to 2017. This MSK condition represents the most important cause of YLDs in Brazil, where the increase in burden is mainly related to increase in population size and ageing. The LBP age-standardized YLDs rate are similar among Brazilian federative units. LBP ranks in the top three causes of DALYs in Brazil, even though it does not contribute to mortality. Conclusions: Findings from this study show LBP to be the most important cause of YLDs and the 3rd leading cause of DALYs in Brazil. The Brazilian population is ageing, and the country has been experiencing a rapid epidemiological transition, which generates an increasing number of people who need chronic care. In this scenario, more attention should be paid to the burden of non-fatal health conditions.


  • Open Access

    The burden of diabetes and hyperglycemia in Brazil: a global burden of disease study 2017

    by Bruce Bartholow Duncan, Ewerton Cousin, Mohsen Naghavi, Ashkan Afshin, Elisabeth Barboza França, Valéria Maria de Azeredo Passos, Deborah Malta, Bruno R. Nascimento, Maria Inês Schmidt

    Background: The Global Burden of Diseases (GBD) 2017 database permits an up-to-date evaluation of the frequency and burden of diabetes at the state level in Brazil and by type of diabetes. The objective of this report is to describe, using these updated GBD data, the current and projected future burden of diabetes and hyperglycemia in Brazil, as well as its variation over time and space. Methods: We derived all estimates using the GBD 2016 and 2017 databases to characterize disease burden related to diabetes and hyperglycemia in Brazil, from 1990 to 2040, using standard GBD methodologies. Results: The overall estimated prevalence of diabetes in Brazil in 2017 was 4.4% (95%UI 4.0–4.9%), with 4.0% of those with diabetes being identified as having type 1 disease. While the crude prevalence of type 1 disease has remained relatively stable from 1990, type 2 prevalence has increased 30% for males and 26% for females. In 2017, approximately 3.3% of all disability-adjusted life years lost were due to diabetes and 5.9% to hyperglycemia. Diabetes prevalence and mortality were highest in the Northeast region and growing fastest in the North, Northeast, and Center-West regions. Over this period, despite a slight decrease in age-standardized incidence of type 2 diabetes, crude overall burden due to hyperglycemia has increased 19%, with population aging being a main cause for this rise. Cardiovascular diseases, responsible for 38.3% of this burden in 1990, caused only 25.9% of it in 2017, with premature mortality attributed directly to diabetes causing 31.6% of the 2017 burden. Future projections suggest that the diabetes mortality burden will increase 144% by 2040, more than twice the expected increase in crude disease burden overall (54%). By 2040, diabetes is projected to be Brazil’s third leading cause of death and hyperglycemia its third leading risk factor, in terms of deaths. Conclusions: The disease burden in Brazil attributable to diabetes and hyperglycemia, already large, is predicted by GBD estimates to more than double to 2040. Strong actions by the Ministry of Health are necessary to counterbalance the major deleterious effects of population aging.


  • Open Access

    Pandemia da COVID-19 no Brasil: Projeções do Institute for Health Metrics and Evaluation e a Evolução Observada

    by Caroline Stein, Ewerton Cousin, Deborah Carvalho Malta, Antonio Luiz Pinho Ribeiro, Ísis Eloah Machado, Ana Maria Nogales Vasconcelos, Ana Paula Souto Melo, Elisabeth França, Lenice Ishitani, Mariana Santos Felisbino-Mendes, et al.

    Objetivo: Descrever as projeções do IHME para a COVID-19 no Brasil e seus estados e discutir acurácia e implicações em diferentes cenários. Métodos: Descrevemos e estimamos a acurácia das previsões para o Brasil, comparando-as com as mortes cumulativas observadas. Resultados: A projeção prevê 192.511 mortes causadas pela pandemia até 1 de dezembro de 2020. O relaxamento continuado do isolamento físico obrigatório, apesar do aumento continuado dos óbitos, pode causar >63.000 mortes adicionais; o rápido aumento no uso de máscara pode reduzir o número para ~25.000. Vários estados poderão ter que reinstituir restrições. As diferenças entre as projeções do IHME até 6 semanas e as mortes registradas variaram de -11% a 48% para o Brasil. Conclusões: As projeções de curto a médio prazo do IHME fornecem informações válidas para informar os gestores de saúde, autoridades eleitas e a sociedade em geral. Elas sugerem curso prolongado, grande mortalidade e prováveis novas restrições.

  • Open Access

    Qualidade do consumo alimentar e fatores associados em crianças de um ano de vida na Atenção Primária à Saúde

    by Laura Garcia de Freitas, Margarita Alexandra Pena Cortés, Caroline Stein, Ewerton Cousin, Daniel Demétrio Faustino-Silva, Juliana Balbinot Hilgert

    Resumo O objetivo foi analisar a qualidade do consumo alimentar de crianças com um ano de idade acompanhadas por um serviço de Atenção Primária à Saúde (APS). Trata-se de estudo transversal aninhado a uma coorte de saúde bucal infantil em que foram coletados dados de crianças nascidas em 2013 e acompanhadas por 2 anos, em Porto Alegre. Foi aplicado um questionário sobre variáveis maternas e frequência de consultas de puericultura, medidas antropométricas e consumo alimentar da criança. Para tal, foi gerado um escore a partir da pontuação criada conforme o SISVAN (Sistema de Vigilância Alimentar e Nutricional). Foi calculado um modelo multivariado, por meio da Regressão de Poisson com variância robusta. A amostra consistiu de 249 crianças. Encontrou-se 30,5% (76) de qualidade ruim/regular da alimentação, que no modelo multivariado esteve associada com nível educacional do responsável, sendo até ensino médio incompleto (RP = 2,14, IC95% = 1,03-4,44) e ensino médio completo (RP = 1,70, IC95% = 0,81-3,54), assim como não ter consultado com dentista (RP = 2,54, IC95% = 1,33-4,84) ou ter consultado até o quarto mês de idade (RP = 1,94, IC95% = 1,01-3,72). Conclui-se que não consultar com dentista no primeiro ano de vida e menor escolaridade materna repercutem negativamente na qualidade alimentar infantil.


  • Open Access

    Increasing burden of osteoarthritis in Brazil from 2000 to 2017-- results from the Global Burden of Disease Study (GBD), 2017

    by Amanda Aparecida Oliveira Leopoldino, Fabricio Melo Bertolini, Juliano Vilela Dalia Mesquita, Ewerton Cousin, Valéria Maria de Azeredo Passos

    A osteoartrite (OA) é uma das principais causas de doenças osteomusculares e a segunda causa de incapacidade relacionada ao trabalho entre homens adultos. Existem poucos estudos brasileiros de base populacional. Objetivo: Investigar a carga de OA na população brasileira (50+ anos), de 2000 a 2017. Método: Estudo descritivo das estimativas de OA obtidas em colaboração com o estudo Global Burden of Disease 2017. Como a OA não é causa de óbito, descrevemos a prevalência e anos vividos com incapacidade (YLDs), representando a carga da doença (DALYs). Comparamos as métricas do Brasil com país em desenvolvimento da América Latina (Chile) e países desenvolvidos, com ou sem sistema de saúde pública (Inglaterra e Estados Unidos). Resultados: O número de casos no Brasil quase dobrou de 2000 para 2017. Todos os países apresentaram crescente prevalência padronizada por idade. O Brasil apresentou as menores taxas e aumento (9%) no período. A OA foi da 14ª para 12ª causa de incapacidade entre 2000 e 2017, naqueles de 50 a 69 anos e em 2017. As taxas de YLD de 100.000 habitantes aumentaram mais de três vezes, em homens e mulheres, entre aqueles com 50 a 54 anos e em indivíduos acima de 80 anos. O envelhecimento associou-se a claro aumento da incapacidade para ambos os sexos e anos analisados. Conclusão: Essa primeira estimativa do ônus da OA no Brasil destaca a importância dessa causa de incapacidade para os formuladores de políticas de saúde e chama a atenção para a necessidade de mais investimentos em pesquisa.


  • Open Access

    Ocorrência de dor combinada na coluna lombar, cintura pélvica e sínfise púbica entre gestantes do extremo sul do Brasil

    by Rodrigo Dalke Meucci, Aline Henriques Perceval, Daniele Ramos de Lima, Ewerton Cousin, Luana Patrícia Marmitt, Paula Pizzato, Priscila Arruda da Silva, Stephanie Jesien, Juraci Almeida Cesar

    RESUMO: Objetivos: Estimar a prevalência e caracterizar a ocorrência de dor lombar gestacional (DLG), dor na cintura pélvica posterior (DCPP) e dor na sínfise púbica (DSP) entre gestantes residentes em Rio Grande, RS. Métodos: Estudo transversal realizado com todas as puérperas com parto em 2016. Foram utilizadas duas figuras para investigar a presença de DLG, DCPP e DSP de forma isolada ou combinada. Regressão logística multinomial foi usada para avaliar os fatores associados a cada sintoma. Resultados: DLG foi referida por 42,2% das entrevistadas, DSP por 4,9%, e DCPP por 2%, enquanto DLG + DSP por 9%, DLG + DCPP por 2,8%, DCPP + DSP por 1,1% e dor nas três regiões por 3,9% delas. Quanto maior era a idade da gestante, menor foi o risco de DLG e de DLG combinada a uma das regiões da cintura pélvica e maior o risco de DCPP + DSP. Depressão na gestação aumentou o risco de todas as combinações dos sintomas. Conclusão: Este estudo realizou uma descrição mais detalhada da ocorrência dos desfechos avaliados e de seus fatores associados. Estudos como este são raros no país, sobretudo com baixas taxas de perdas e recusas. A elevada prevalência dos sintomas avaliados sugere que sua investigação seja rotineira nas consultas de pré-natal, atendo-se a idade das gestantes, sintomas depressivos e a dores combinadas e intensas.